Related Experiment Video
Updated: May 2, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer
Hideya Onishi1, Mitsuo Katano1
1Hideya Onishi, Mitsuo Katano, Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Abstract:
Pancreatic cancer is one of the most aggressive and difficult cancers to treat. Despite numerous research efforts, limited success has been achieved in the therapeutic management of patients with this disease. In the current review, we focus on one component of morphogenesis signaling, Hedgehog (Hh), with the aim of developing novel, effective therapies for the treatment of pancreatic cancer. Hh signaling contributes to the induction of a malignant phenotype in pancreatic cancer and is responsible for maintaining pancreatic cancer stem cells. In addition, we propose a novel concept linking Hh signaling and tumor hypoxic conditions, and discuss the effects of Hh inhibitors in clinical trials. The Hh signaling pathway may represent a potential therapeutic target for patients with refractory pancreatic cancer.
Insights
Pancreatic cancer remains challenging to treat. This review explores Hedgehog (Hh) signaling as a potential therapeutic target, highlighting its role in cancer stem cells and tumor hypoxia for novel treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic cancer is highly aggressive with limited therapeutic options.
- Hedgehog (Hh) signaling is implicated in cancer development and maintenance.
- Tumor hypoxia is a critical factor in pancreatic cancer progression.
Purpose of the Study:
- To review the role of Hedgehog (Hh) signaling in pancreatic cancer.
- To explore the link between Hh signaling and tumor hypoxia.
- To evaluate Hh inhibitors as potential therapies for pancreatic cancer.
Main Methods:
- Literature review of studies on Hh signaling in pancreatic cancer.
- Analysis of Hh pathway's role in cancer stem cells and malignant phenotype.
- Discussion of clinical trial data for Hh inhibitors.
Main Results:
- Hh signaling promotes pancreatic cancer malignancy and maintains cancer stem cells.
- A novel link between Hh signaling and tumor hypoxic conditions is proposed.
- Hh inhibitors show potential in clinical trials for refractory pancreatic cancer.
Conclusions:
- The Hedgehog (Hh) signaling pathway is a promising therapeutic target for pancreatic cancer.
- Targeting Hh signaling, potentially in combination with addressing hypoxia, could improve treatment outcomes.
- Further research and clinical trials are warranted to validate Hh inhibitors for pancreatic cancer therapy.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies
There are several types of targeted therapies against...

